Benzodiazepine use and hepatitis C seroconversion in a cohort of persons who inject drugs

P. Bach, G. Walton, K. Hayashi, M.-J. Milloy, H. Dong, T. Kerr, J. Montaner and E. Wood

American Journal of Public Health, 2016, vol. 106, issue 6, 1067-1072

Abstract: Objectives. To examine the relationship between benzodiazepine (BZD) use and HCV seroconversion in 2 linked prospective cohorts of persons who inject drugs (PWID). Methods.We examined prospective cohorts of 440 PWID (baseline BZD users: n = 102; 23.2%) from the AIDS Care Cohort to Evaluate Access to Survival Services (ACCESS) and the Vancouver Injection Drug Users Study (VIDUS) cohorts, followed-up from 1996 to 2013 in Vancouver, Canada. Results. At baseline, the prevalence of HCV was higher among those who used BZD (80.5% vs 61.5%; P

Keywords: benzodiazepine derivative, Canada; female; Hepacivirus; hepatitis C; human; immunology; male; prevalence; prospective study; seroconversion; substance abuse; transmission; young adult, Benzodiazepines; Canada; Female; Hepacivirus; Hepatitis C; Humans; Male; Prevalence; Prospective Studies; Seroconversion; Substance Abuse, Intravenous; Young Adult (search for similar items in EconPapers)
Date: 2016
References: Add references at CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.2105/AJPH.2016.303090

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:aph:ajpbhl:10.2105/ajph.2016.303090_0

DOI: 10.2105/AJPH.2016.303090

Access Statistics for this article

American Journal of Public Health is currently edited by Alfredo Morabia

More articles in American Journal of Public Health from American Public Health Association
Bibliographic data for series maintained by Christopher F Baum ().